California-based Corium unveils plans for a $66 million initial public offering for its transdermal drug delivery technology.
Drug-delivery devices maker Corium could raise up to $66 million through an initial public offering, the company announced in SEC filings today.
Corium plans to offer 5.5 million shares of common stock for $10-$12 apiece, putting its total offering value at between $55-$66 million. At the middle rate of $11 per share, Corium expects its net proceeds to amount to $53.7 million after expenses.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1psJDpw
Cap comentari:
Publica un comentari a l'entrada